Researchers believe implementation of treatment guidelines for children with sickle cell disease with acute chest syndrome may decrease hospital readmission rates.
NSAIDs were found to be inferior to antibiotics for symptom relief of uncomplicated urinary tract infection.
Vabomere is now available for the treatment of adults (≥18 years old) with complicated urinary tract infections.
Secnidazole is a 5-nitroimidazole with demonstrated in vitro antimicrobial activity against many anaerobic Gram-negative and Gram-positive bacterial species, while sparing Lactobacillus species.
Three new guidelines discuss the best practice for Helicobacter pylori treatment.
Repeated intravenous administration of penicillin antibiotics appears to be safe in patients with a reported penicillin allergy and a negative penicillin allergy test.
The FDA has approved the first oral treatment for bacterial vaginosis.
Looking for a way to reduce inappropriate antibiotic use for adults with acute sore throats, researchers evaluated whether as single dose of oral corticosteriod can effectively reduce likelihood of symptom resolution.
Older age and peaked tympanogram are associated with reduced risk of treatment failure in young children with acute otitis media.
Vabomere, formerly known as Carbavance, is approved for patients with complicated UTI including pyelonephritis.
The addition of bismuth subcitrate to levofloxacin-based triple therapy is not associated with increased effectiveness in patients with Helicobacter pylori infection.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Pediatric Outpatient Antimicrobial Stewardship: Minimizing Antibiotic Duration
- Better Detection and Treatment Needed for H pylori Infections in Children
- Are Antibiotic Stewardship Programs the Antidote to Antibiotic Overuse?
- FDA Approves New Hepatitis B Vaccine for Adults
- Strategies for Preventing Antibiotic Resistance in Acne